CADL
Price
$6.08
Change
+$0.21 (+3.58%)
Updated
Dec 24 closing price
Capitalization
333.78M
91 days until earnings call
Intraday BUY SELL Signals
CYYNF
Price
$0.15
Change
+$0.03 (+25.00%)
Updated
Nov 17 closing price
Capitalization
48.53M
Intraday BUY SELL Signals
Interact to see
Advertisement

CADL vs CYYNF

Header iconCADL vs CYYNF Comparison
Open Charts CADL vs CYYNFBanner chart's image
Candel Therapeutics
Price$6.08
Change+$0.21 (+3.58%)
Volume$345.87K
Capitalization333.78M
Cynata Therapeutics
Price$0.15
Change+$0.03 (+25.00%)
Volume$2K
Capitalization48.53M
CADL vs CYYNF Comparison Chart in %
CADL
Daily Signal:
Gain/Loss:
CYYNF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CADL vs. CYYNF commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CADL is a Buy and CYYNF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 26, 2025
Stock price -- (CADL: $6.08 vs. CYYNF: $0.15)
Brand notoriety: CADL and CYYNF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CADL: 43% vs. CYYNF: 61%
Market capitalization -- CADL: $333.78M vs. CYYNF: $48.53M
CADL [@Biotechnology] is valued at $333.78M. CYYNF’s [@Biotechnology] market capitalization is $48.53M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CADL’s FA Score shows that 0 FA rating(s) are green whileCYYNF’s FA Score has 0 green FA rating(s).

  • CADL’s FA Score: 0 green, 5 red.
  • CYYNF’s FA Score: 0 green, 5 red.
According to our system of comparison, CYYNF is a better buy in the long-term than CADL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CADL’s TA Score shows that 6 TA indicator(s) are bullish while CYYNF’s TA Score has 3 bullish TA indicator(s).

  • CADL’s TA Score: 6 bullish, 4 bearish.
  • CYYNF’s TA Score: 3 bullish, 1 bearish.
According to our system of comparison, CADL is a better buy in the short-term than CYYNF.

Price Growth

CADL (@Biotechnology) experienced а +10.55% price change this week, while CYYNF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Reported Earning Dates

CADL is expected to report earnings on Mar 26, 2026.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CADL($334M) has a higher market cap than CYYNF($48.5M). CYYNF YTD gains are higher at: -21.053 vs. CADL (-29.954). CYYNF has higher annual earnings (EBITDA): -10.8M vs. CADL (-20.74M).
CADLCYYNFCADL / CYYNF
Capitalization334M48.5M689%
EBITDA-20.74M-10.8M192%
Gain YTD-29.954-21.053142%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash87MN/A-
Total Debt7.21MN/A-
FUNDAMENTALS RATINGS
CYYNF: Fundamental Ratings
CYYNF
OUTLOOK RATING
1..100
38
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CADLCYYNF
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
9%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
42%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
17%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
15%
Advances
ODDS (%)
Bullish Trend 4 days ago
84%
N/A
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
27%
View a ticker or compare two or three
Interact to see
Advertisement
CADL
Daily Signal:
Gain/Loss:
CYYNF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CHDRY170.80N/A
N/A
Christian Dior S.E.
DAUGF0.04N/A
N/A
Desert Gold Ventures Inc.
LYBC46.33N/A
N/A
Lyons Bancorp, Inc.
ELRXF5.95N/A
N/A
AB Electrolux
QBCRF37.76-0.25
-0.66%
Quebecor Inc.

CADL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CADL has been loosely correlated with CYYNF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CADL jumps, then CYYNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CADL
1D Price
Change %
CADL100%
+3.58%
CYYNF - CADL
46%
Loosely correlated
N/A
MGX - CADL
46%
Loosely correlated
+1.16%
RPTX - CADL
44%
Loosely correlated
+17.51%
RXRX - CADL
40%
Loosely correlated
+0.92%
PRTA - CADL
39%
Loosely correlated
+2.11%
More

CYYNF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYYNF has been loosely correlated with CADL. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CYYNF jumps, then CADL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYYNF
1D Price
Change %
CYYNF100%
N/A
CADL - CYYNF
46%
Loosely correlated
+3.58%
URGN - CYYNF
38%
Loosely correlated
+1.54%
MLLCF - CYYNF
31%
Poorly correlated
N/A
INKT - CYYNF
27%
Poorly correlated
-1.16%
BRTX - CYYNF
26%
Poorly correlated
+2.59%
More